Загрузка...
Translational metabolomics in cancer research
Over the last decade there has been a bottleneck in the introduction of new validated cancer metabolic biomarkers into clinical practice. Unfortunately, there are no biomarkers with adequate sensitivity for the early detection of cancer, and there remain a reliance on cancer antigens for monitoring...
Сохранить в:
| Опубликовано в: : | Biomark Med |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4718447/ https://ncbi.nlm.nih.gov/pubmed/26329905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/bmm.15.52 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|